397 related articles for article (PubMed ID: 26387028)
1. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).
Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
Int J Clin Exp Med; 2015; 8(11):21565-71. PubMed ID: 26885106
[TBL] [Abstract][Full Text] [Related]
3. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
5. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
[TBL] [Abstract][Full Text] [Related]
6. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention.
Guo J; Zhang WZ; Zhao Q; Wo JS; Cai SL
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4457-4463. PubMed ID: 29077146
[TBL] [Abstract][Full Text] [Related]
7. Anti-oxidative stress effect of loading-dose rosuvastatin prior to percutaneous coronary intervention in patients with acute coronary syndrome: a prospective randomized controlled clinical trial.
Liang D; Zhang Q; Yang H; Zhang R; Yan W; Gao H; Wang J; Zhang X; Chen Y; Cao F
Clin Drug Investig; 2014 Nov; 34(11):773-81. PubMed ID: 25186834
[TBL] [Abstract][Full Text] [Related]
8. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
He W; Cao M; Li Z
Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin reduces ischemia-reperfusion injury in patients with acute coronary syndrome treated with percutaneous coronary intervention.
Jiang F; Yang J; Zhang L; Li R; Zhuo L; Sun L; Zhao Q
Clin Cardiol; 2014 Sep; 37(9):530-5. PubMed ID: 25156269
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Trial of Creatine-kinase Leak After Rosuvastatin in Elective Percutaneous Coronary Intervention (CLEAR-PCI).
Martins KB; Mattos LA; Sousa AG; Sousa JE; Abzaid A; Feres F; de Ribamar JC; Staico R; Costa RA; Chaves AJ
J Interv Cardiol; 2015 Aug; 28(4):339-47. PubMed ID: 26086603
[TBL] [Abstract][Full Text] [Related]
11. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
Int J Cardiol; 2009 Nov; 137(3):246-51. PubMed ID: 18706705
[TBL] [Abstract][Full Text] [Related]
12. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
[TBL] [Abstract][Full Text] [Related]
13. The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI).
Dastan F; Salamzadeh J; Alipour-Parsa S; Sharif Kashani B; Hashempour MM
Iran J Pharm Res; 2019; 18(Suppl1):282-290. PubMed ID: 32802107
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
[TBL] [Abstract][Full Text] [Related]
15. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
Shehata M; Fayez G; Nassar A
Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
[TBL] [Abstract][Full Text] [Related]
16. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
19. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
[TBL] [Abstract][Full Text] [Related]
20. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
